Cannabis News

Subscribe

News by Topic

  • Business
  • Legalization
  • Medical Industry
  • Adult Use Industry
  • Hemp Industry
  • Cannabidiol
  • Stocks
  • Regulations
  • International
  • Entrepreneurs
  • Federal Policy
  • Licensing
  • Banking
  • Marketing
  • Technology
  • Celebrities
  • Sports

News by Region

Adult Use Markets:

  • Canada
  • CA
  • CO
  • WA
  • OR
  • NV
  • DC
  • IL
  • MI
  • MA
  • ME
  • AK
  • VT
  • AZ
  • VA
  • MT
  • NM
  • NY
  • NJ
  • CT
  • Mexico

Medical Markets:

  • FL
  • RI
  • AR
  • AL
  • MD
  • NH
  • DE
  • SD
  • ND
  • OH
  • OK
  • PA
  • View All

Podcasts

Listen

Q&A Interviews

Read

Business Index

Sign Up

Popular Categories

  • Accounting & Bookkeeping
  • Branding Agencies
  • Payment Processing
  • Startup Consulting
  • Business Insurance
  • Cannabis Investors
  • Lawyers & Legal Firms
  • Security Solutions
  • Business Software
  • Staffing & Recruiting
  • Cannabis Testing Labs
  • View All

Announcements

Submit

CBD Product Directory CBD Product Index

Browse

Resources

  • Cannabias

  • Fresh Cut

  • Spotlight

  • Events

  • Reviews

  • Books

  • Vocabulary

  • Stocks

  • About Us
  • Subscribe
  • Advertise
Create Business Profile

The endocannabinoid system and liver diseases.

Subject: Liver Disease - PUBLISHED VIA Journal of Neuroendocrinology

Author(s):
Caraceni P, Domenicali M, Bernardi M

Department of Internal Medicine, Cardioangiology, Hepatology, Alma Mater Studiorum University of Bologna, Bologna, Italy. paolo.caraceni@unibo.it

View Source >>

Related Studies:

Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.

Published via British Journal of Pharmacology

Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.

Published via PLOS ONE

Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.

Published via European Journal of Pharmacology

Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.

Published via Cell Death & Disease

Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Published via Author Manuscript

View all medical studies

Learn More About Cannabis

what are cannabinoids

What Are Cannabinoids and How Do They Work?

Mon / Nov 30th

Cannabis & CBD Topicals: Do They Work?

Wed / Oct 7th

What Are Cannabis Topicals?

Fri / Feb 5th

a word from our sponsors:

become a sponsor

advertisement

advertise here

Subscribe for Updates

Esssential cannabis industry news & insights, delivered daily.

  • Cannabis News

    • Business News
    • Politics / Legalization News
    • Medical News
    • Industrial Hemp News
    • Recreational Marijuana
    • CBD News
  • News by Market

    • Canada
    • CA
    • CO
    • WA
    • OR
    • NV
    • DC
    • IL
    • MI
    • MA
    • ME
    • AK
    • VT
    • AZ
    • VA
    • MT
    • NM
    • NY
    • NJ
    • CT
    • Mexico
    • AZ
    • AR
    • FL
    • IL
    • MD
    • MI
    • NH
    • NJ
    • NY
    • OH
    • OK
    • PA
    • TX
    • UT
  • Business Index

    • Create a Profile
    • Stocks & Finance
  • CBD Product Index

    • View All

Podcasts

Q&A Interviews

Press Releases

  • Events

    • Full Calendar
    • Submit Event
  • Jobs / Careers

    • Find a Job
    • Hire
  • Cannabias

  • Fresh Cut

  • Product Reviews

  • Spotlight

  • Books

  • Vocabulary

  • Digital Assets

Trusted cannabis industry resources.

  • About
  • Contact
  • Advertise

We're proud to support:

  • National Cannabis Industry Association
  • The Cannabis Alliance
  • Minority Cannabis Business Association

Copyright 2023 © Ganjapreneur.com // All rights reserved. // Terms of Use // Advertising Policy

DISCLAIMER: Ganjapreneur.com is intended as an educational resource for law-abiding professionals and those who are curious about entrepreneurial and/or investment opportunities in emerging markets. We do not offer investment advice, and we encourage all visitors and readers to do their own due dilligence before investing in any of the companies or markets that we write about. Be advised that possessing, using, distributing and selling cannabis are all federal crimes in the United States of America and the articles, pages, links, and other types of information on this site are not intended to assist you in violating federal law. Ganjapreneur.com and all associated entities and individuals are not responsible for third party content and/or links published on this website.

Website & branding by the Ganjapreneur in-house agency:

Blue Dream - Uplifted cannabis industry branding & marketing.

Uplifted cannabis industry branding & marketing.